Sinovac Biotech SVA Balance Sheet (2009-2026)

NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT
Reported Financials

Sinovac Biotech Quarterly Balance Sheet

Periods 55 quarters
Latest Jun 2026

Sinovac Biotech reported total assets of $8.14B and total liabilities of $1.67B for the quarter ended Jun 2026, down 36.9% year over year. This balance sheet covers 55 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
158.17M149.05M151.69M156.70M152.72M165.34M141.34M150.24M1,041.01M6,843.65M11,608.86M6,857.91M3,878.68M1,643.03M1,123.96M1,072.35M335.27M182.63M488.25M322.26M
Short-term InvestmentsInvestments (Current)
18.91M19.37M18.94M19.59M50.27M21.18M35.39M33.88M135.25M2,973.70M1,806.45M4,988.24M6,653.67M9,425.78M9,894.58M9,502.19M9,613.33M5,777.75M5,483.07M5,200.96M
Cash & Current Investments
177.08M168.42M170.63M176.28M202.99M186.53M176.72M184.11M1,176.26M9,817.35M13,415.30M11,846.15M11,068.80M97.94M10,574.54M9,948.60M5,960.38M5,971.32M5,523.21M
Receivables - NetNet Receivables
74.46M79.50M96.58M104.81M113.74M97.60M106.01M169.90M253.49M1,393.08M942.74M969.56M486.59M425.25M424.95M370.17M300.89M306.84M286.34M265.90M
Receivables - OtherOther Receivables
18.09M3.20M30.98M31.02M22.65M23.85M19.35M34.28M20.40M26.00M
Receivables
92.55M79.50M96.58M104.81M116.93M97.60M106.01M169.90M253.49M1,393.08M973.71M969.56M517.61M425.25M447.60M394.02M320.24M341.12M306.75M291.90M
Raw Materials
4.84M5.69M29.01M111.71M88.00M61.65M31.59M25.84M
Work In Process
3.93M8.57M52.52M141.33M41.12M39.37M37.05M38.88M
Finished Goods
16.33M13.59M24.29M138.03M46.17M34.59M28.28M29.59M
Inventory
25.09M29.78M32.63M29.47M27.85M36.15M45.76M56.69M105.81M407.66M391.07M266.86M175.29M182.74M135.61M153.52M96.92M109.14M94.31M106.61M
Current Deferred Tax AssetsCurrent Deferred Tax
-12.11M-90.56M-155.75M-68.90M
Prepaid Assets
4.54M3.05M3.94M2.80M1.87M5.97M6.29M10.60M15.54M58.20M150.23M23.33M18.37M13.31M13.05M14.16M15.72M10.60M17.60M23.99M
Current Assets
284.18M283.22M303.79M313.36M349.61M329.35M338.00M424.77M1,560.29M11,689.01M14,937.76M13,115.09M11,304.69M11,769.03M11,597.30M11,148.28M10,644.52M10,376.79M7,064.50M6,624.41M
Non-Current Assets
Buildings
266,455.00M326,902.00M395.17M411.14M
Construction in Progress
166.17M327,778.00M146.81M178.95M
Land & Improvements
7.23M7.27M7.02M6.23M
Property, Plant & Equipment (Net)PP&E (Net)
70.92M73.85M73.83M72.13M74.31M72.52M110.75M142.23M200.37M636.85M855.04M949.42M989.73M1,058.96M951.98M934.61M880.97M858.56M706.06M697.07M
Long-Term Investments
99.49M149.09M609.06M655.84M697.12M1,426.08M657.77M879.84M880.37M491.35M498.79M512.32M576.09M
Goodwill
27.51M11.80M12.60M12.98M
Intangibles
8.71M8.23M7.63M6.64M6.40M1.28M1.46M1.47M1.40M1.48M1.32M9.70M8.75M8.52M7.84M122.58M74.80M77.68M79.23M
Goodwill & Intangibles
8.71M8.23M7.63M6.64M6.40M1.28M1.46M1.47M1.40M1.48M1.32M9.70M8.75M8.52M7.84M150.09M86.59M90.28M92.21M
Long-Term Deferred Tax
5.80M6.60M7.13M8.19M11.37M12.22M13.68M16.76M26.89M140.00M27.56M64.82M30.13M98.69M38.23M36.39M37.37M34.56M41.52M37.85M
Other Non-Current Assets
0.02M0.90M2.53M1.42M0.02M5.04M3.80M10.09M0.03M27.59M1.61M129.72M19.21M2.31M20.91M18.67M20.49M19.78M18.28M18.33M
Non-Current Assets
85.61M98.63M100.04M97.29M102.69M103.97M191.36M233.78M341.03M938.80M1,820.94M1,950.70M2,725.86M1,955.99M2,014.72M1,748.66M1,692.77M1,610.28M1,477.23M1,514.38M
Assets
369.78M381.85M403.83M410.65M452.30M433.32M529.37M658.56M1,901.33M12,627.81M16,758.69M15,065.78M14,030.54M13,725.01M13,612.02M12,896.94M12,337.28M11,987.07M8,541.73M8,138.79M
Liabilities
Current Liabilities
Accounts Payables
49.99M46.62M55.11M55.19M58.89M46.42M70.83M117.00M211.43M958.87M1,029.69M334.29M924.65M819.53M989.25M689.14M803.00M590.13M604.68M250.23M
Notes Payables
3.32M4.07M5.92M3.74M5.93M11.68M14.84M30.28M32.94M22.36M3.10M0.10M0.29M201.12M76.09M179.35M211.92M214.96M229.37M148.05M
Dividends payables
0.61M2.10M3.62M5.13M6.62M8.12M9.63M11.14M587.85M20.08M118.89M139.55M119.37M212.96M3,958.19M657.86M657.18M
Payables
53.31M51.30M63.13M62.55M69.95M64.72M93.79M156.91M255.51M1,569.07M1,032.79M354.48M1,043.84M1,160.20M1,065.33M987.87M1,227.88M4,763.28M1,491.91M1,055.45M
Accumulated Expenses
26.81M31.15M113.69M496.96M240.09M185.37M156.60M152.71M
Other Accumulated Expenses
1.36M0.52M4.68M18.07M3.00M1.62M0.90M1.35M2.77M
Short term Debt
3.32M1.59M15.12M1.59M1.73M
Current Leases
6.83M6.43M6.27M5.76M5.63M55.01M57.61M85.49M110.25M112.47M57.12M52.52M40.93M112.47M12.39M13.20M12.70M
Current Taxes
0.88M5.01M1.90M1.75M4.11M9.80M35.26M1,366.19M1,392.50M158.54M161.55M192.66M187.05M207.72M221.91M30.69M16.69M
Current Deferred Revenue
2.91M2.11M2.61M3.52M5.46M4.40M4.55M7.34M363.79M334.66M79.72M32.76M25.54M15.15M27.05M6.17M12.21M12.01M11.27M9.43M
Current Deferred Tax LiabilityCurrent Deferred Tax
540.73M
Total Current Liabilities
58.21M56.55M69.82M74.27M87.20M81.29M113.52M193.86M679.61M3,307.74M2,518.57M564.86M1,256.40M1,189.63M1,292.71M1,152.28M1,451.90M5,001.41M1,540.37M1,091.16M
Non-Current Liabilities
Non-Current Debt
3.89M1.99M0.21M0.18M2.16M12.55M12.67M12.15M11.51M10.99M177.82M130.32M163.84M233.06M265.48M233.12M
Convertible Debt
14.66M14.69M
Non-Current Deferred Revenue
5.96M1.93M1.80M2.23M3.99M3.40M4.07M13.07M4.23M14.59M15.84M11.21M4.48M4.13M5.87M0.81M4.84M1.74M5.89M6.08M
Preferred Stock Liabilities
13,876.01M
Minority Interest
38.50M41.20M45.23M47.36M58.18M55.72M58.30M70.86M373.65M3,257.05M4,558.16M4,625.85M3,752.59M3,572.39M3,326.73M2,896.54M2,031.17M1,973.38M1,957.31M1,959.47M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
2.72M56.13M540.73M325.92M462.10M239.03M453.92M387.04M410.05M392.04M325.07M335.87M
Operating Leases
1.21M1.40M0.97M5.76M0.53M0.49M0.45M85.49M9.90M112.47M6.37M52.52M5.99M38.99M2.45M13.20M2.46M8.64M7.63M
Other Non-Current Liabilities
9.71M3.07M3.02M2.90M3.16M1.70M1.70M1.77M7.00M7.11M5.03M0.14M0.04M0.63M0.04M0.43M0.02M0.02M0.02M0.03M
Total Non-Current Liabilities
19.65M25.01M22.22M22.72M12.91M12.54M77.87M87.45M101.59M189.91M686.96M407.07M530.85M298.13M676.83M535.96M591.95M642.18M605.11M582.73M
Total Liabilities
77.85M81.56M92.04M96.98M100.10M93.83M191.38M281.31M770.06M3,497.65M3,205.52M971.93M1,787.25M1,487.75M1,969.55M1,389.94M2,043.85M5,643.59M2,145.47M1,673.88M
Shareholder's Equity
Total Debt
7.21M6.06M5.92M3.74M5.93M11.68M15.05M30.46M35.10M34.91M17.36M12.25M26.93M212.11M255.49M309.67M377.49M448.02M494.86M381.17M
Common Equity
291.93M300.29M311.79M313.67M352.20M339.50M337.99M377.25M1,131.27M9,130.16M13,553.17M14,093.86M12,243.30M12,237.26M11,642.48M11,507.00M10,293.43M6,343.48M6,396.25M6,464.90M
Liabilities and Shareholders Equity
369.78M381.85M403.83M410.65M452.30M433.32M529.37M658.56M1,901.33M12,627.81M16,758.69M15,065.78M14,030.54M13,725.01M13,612.02M12,896.94M12,337.28M11,987.07M8,541.73M8,138.79M
Retained Earnings
23.82M25.00M35.66M41.94M56.73M49.37M44.12M53.77M144.24M5,249.61M6,813.65M7,623.37M6,804.40M7,239.95M6,789.34M7,107.64M6,838.36M2,858.50M2,815.94M2,755.71M
Preferred Shares
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.02M

Sinovac Biotech Balance Sheet API

Pull Sinovac Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SVA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY